The University of Nebraska Board of Regents will consider the appointment of James Linder, M.D., of Omaha, as interim president of the university. That’s scheduled for Friday.
Current NU President James B. Milliken is leaving Nebraska to become chancellor of the City University of New York. A national search is underway for Milliken’s successor. By mutual agreement with the Board, Dr. Linder will not be a candidate for the permanent position.
Linder currently serves part-time as senior associate to the president of the University of Nebraska for innovation and economic competitiveness and as president of the University Technology Development Corporation.
He also holds a faculty appointment as professor of pathology and microbiology at the University of Nebraska Medical Center. In addition to his NU employment, Linder serves as chief medical officer of Roche Diagnostics Hematology of Boston.
“The Board of Regents considered several outstanding candidates for interim president, and Jim Linder emerged as our consensus top choice to lead the University of Nebraska during this period of transition,” said Howard Hawks, Chairman of the Board of Regents. “Dr. Linder is very familiar with the university, having served in faculty and administrative positions at UNMC and in the Office of the President on a full- or part-time basis for more than 30 years.”
If approved, the appointment would be effective May 3rd.